Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease

Clinical Biochemistry

Volumn 41, Issue 6, 2008, Pages 375-380

  Alamdari, Daryoush Hamidi ^a   Ghayour Mobarhan, Majid ^b   Tavallaie, Shima ^b   Parizadeh, Mohammad Reza ^b   Moohebati, Mohsen ^b   Ghafoori, Fahimeh ^b   Kazemi Bajestani, Seyyed Mohammad Reza ^b   Paletas, Konstantinos ^c   Pegiou, Theodosia ^a   Koliakos, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Medical School   (Greece)

Author keywords

Angiography; Coronary artery disease; Oxidative stress method; Prooxidant antioxidant balance; Risk factor

Indexed keywords

ANTIOXIDANT; BILIRUBIN; CREATININE; GLUCOSE; OXIDIZING AGENT; UREA;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 40849136198     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.12.008     Document Type: Article

References (34)

1. Thom T.J. International mortality from heart disease: rates and trends. Int J Epidemiol 18 (1989) S20-S28
2. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
3. Bierman E.L. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Atherioscler Thromb 12 (1992) 647-656
4. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular disease. The role of oxidant stress. Circ Res 87 (2000) 840-844
5. Landmesser U., Spiekermann S., Dikalov S., et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure. Circulation 106 (2002) 3073-3078
6. Ostend B., and Bjorklid E. Role of monocytes in atherogenesis. Phisiol Rev 83 (2003) 1069-1112
7. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
8. Kotur-Stevuljevic J., Memon L., Stefanovic A., et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 40 (2007) 181-187
9. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
10. Jay D., Hitomi H., and Griendling K.K. Oxidative stress and diabetic cardiovascular complications. Free Radical Biol Med 40 (2006) 183-192
11. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd edn (1999), Oxford Science Publications, Oxford
12. Singh U., and Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 13 (2006) 129-142
13. Alamdari D.H., Paletas K., Pegiou T., et al. Novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 40 (2007) 248-254
14. Marroquin O., Kip K., Kelley D.E., et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 109 (2004) 714-721.
15. Josephy P.D., Mason R.P., and Eling T. Cooxidation of the clinical reagent 3,5, 3′5′-tetramethylbenzidine by prostaglandin synthase. Cancer Res. 42 (1982) 2567-2570
16. Misono Y., Ohkata Y., Morikawa T., and Itoh K. Resonance Raman and absorption spectroscopic studies on the electrochemical oxidation processes of 3,3′,5,5′-tetramethylbenzidine. J Electroanal Chem 436 (1997) 203-212
17. Gutteridge, and Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15 (1990) 129-135
18. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38 (2005) 1103-1111
19. Sugherini L., Valentini M., Cambiaggi C., et al. Determination of a redox compensation index and its relationships to glycaemic control in type 2 diabetes mellitus. Clin Chem Lab Med 38 (2000) 983-987.
20. Prior R.L., and Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27 (1999) 1173-1181
21. Trotti R., Carratelli M., Barbieri M., et al. Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease. Haematologica 86 (2001) 85-91
22. Vassalle C., Boni C., Cecco P.D., and Landi P. Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. Intern J Cardiol 110 (2006) 415-416
23. Botto N., Masetti S., Petrozzi L., et al. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 13 (2002) 269-274
24. Vassalle C., Petrozzi L., Botto N., Andreassi M.G., and Zucchelli G.C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 256 (2004) 308-315
25. Schwedhelm E., Bartling A., et al. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 109 (2004) 843-848
26. Walter M.F., Jacob R.F., Jeffers B., et al. PREVENT Study. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 44 (2004) 1996-2002
27. Jung H.H., Choi D.H., and Lee S.H. Serum malondialdehyde and coronary artery disease in hemodialisis patients. Am J Nephrol 24 (2004) 537-542
28. Bridges A.B., Scott N.A., Pringle T.H., et al. Relationship between the extent of coronary artery disease and indicators of free radical activity. Clin Cardiol 15 (1992) 169-174
29. Nojiri S., Daida H., Mokuno H., Iwama Y., Mae K., Ushio F., and Ueki T. Association of serum antioxidant capacity with coronary artery disease in middle-aged men. Jpn Heart J 42 (2001) 677-690
30. Kadota K., Yui Y., Hattori R., Murohara Y., and Kawai C. Decreased sulfhydryl groups of serum albumin in coronary artery disease. Jpn Circ J 55 (1991) 937-941
31. Healy J., and Tipton K. Ceruloplasmin and what it might do. J Neural Transm 114 (2007) 777-781
32. Swei A., Lacy F., DELano F.A., and Schmid-Schonbein G.W. Oxidative stress in the Dahl hypertensive rat. Hypertension 16 (1998) 291-303
33. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
34. Chrysohoou C., Panagiotakos D.B., Pitsavos C., et al. The association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study. Atherosclerosis 192 (2007) 169-176